Increased levels of interleukin-10 in saliva of Sjogrens's syndrome patients. Correlation with disease activity

被引:46
作者
Bertorello, R
Cordone, MP
Contini, P
Rossi, P
Indiveri, F
Puppo, F
Cordone, G
机构
[1] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy
[2] Univ Genoa, ENT Dept, I-16132 Genoa, Italy
关键词
Sjogren's syndrome; interleukin-10; xerophthalmia; xerostomia; erythrocyte sedimentation rate;
D O I
10.1007/s10238-004-0049-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the study was to determine the levels of interleukin (IL)-10, IL-2, IL-4, and interferon-gamma in the saliva of patients with Sjogren's syndrome and to correlate them with laboratory and clinical parameters of disease activity. The levels of IL-2, IL- 4, IL-10, and interferon-gamma were measured in salivary samples, obtained directly from the Stenone duct of 14 Sjogren's syndrome patients and 26 healthy controls by ELISA. A significant elevation of IL- 10 was found in salivary fluids of Sjogren's syndrome patients compared with healthy controls ( P = 0.007). Elevated interferon. levels were found in some patients. IL-2 and IL-4 were undetectable in all saliva samples. In patients, IL-10 levels significantly correlated with the degree of xerophthalmia and xerostomia ( P = 0.02 and P = 0.01, respectively) and with the erythrocyte sedimentation rate ( P = 0.006). Our data suggest that elevated IL-10 levels are detectable in the saliva of Sjogren's syndrome patients and correlate with the severity of the disease.
引用
收藏
页码:148 / 151
页数:4
相关论文
共 20 条
[1]   Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].
Albert, ML ;
Sauter, B ;
Bhardwaj, N .
NATURE, 1998, 392 (6671) :86-89
[2]  
Anaya JM, 2002, J RHEUMATOL, V29, P1874
[3]   IL-10 is a key cytokine in psoriasis -: Proof of principle by IL-10 therapy:: A new therapeutic approach [J].
Asadullah, K ;
Sterry, W ;
Stephanek, K ;
Jasulaitis, D ;
Leupold, M ;
Audring, H ;
Volk, HD ;
Döcke, WD .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :783-794
[4]   T cell clones from a Sjogren's syndrome salivary gland biopsy produce high levels of IL-10 [J].
Brookes, SM ;
Cohen, SBA ;
Price, EJ ;
Webb, LMC ;
Feldmann, M ;
Maini, RN ;
Venables, PJW .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 103 (02) :268-272
[5]  
DELPRETE G, 1993, J IMMUNOL, V150, P353
[6]   The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjogren's syndrome [J].
Font, J ;
García-Carrasco, M ;
Ramos-Casals, M ;
Aldea, AI ;
Cervera, R ;
Ingelmo, M ;
Vives, J ;
Yagüe, J .
RHEUMATOLOGY, 2002, 41 (09) :1025-1030
[7]  
FOX RI, 1994, J IMMUNOL, V152, P5532
[8]   Current issues in Sjogren's syndrome [J].
Jonsson, R ;
Moen, K ;
Vestrheim, D ;
Szodoray, P .
ORAL DISEASES, 2002, 8 (03) :130-140
[9]   Kinetics of dendritic cell activation:: impact on priming of TH1, TH2 and nonpolarized T cells [J].
Langenkamp, A ;
Messi, M ;
Lanzavecchia, A ;
Sallusto, F .
NATURE IMMUNOLOGY, 2000, 1 (04) :311-316
[10]   Proinflammatory effects of IL-10 during human endotoxemia [J].
Lauw, FN ;
Pajkrt, D ;
Hack, CE ;
Kurimoto, M ;
van Deventer, SJH ;
van der Poll, T .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2783-2789